Authors

• Roger W. Sommi (ORCID: https://orcid.org/0000-0001-8110-8467)
• Daniel J Still (ORCID: https://orcid.org/0000-0001-7749-1643)
• Peter J. Weiden (ORCID: https://orcid.org/0000-0001-5583-5871)
• Sergey Yagoda
• Stephen R. Saklad (ORCID: https://orcid.org/0000-0002-6181-138X)
• Meihua Wang (ORCID: https://orcid.org/0000-0002-0115-1041)

Institutions

• Stony Brook School (US)
• Alkermes (United States) (US)
• Stony Brook University (US)
• University of Missouri–Kansas City (US)

Publication Details

Journal

The Journal of Clinical Psychiatry

Published

2024-08-11

DOI

https://doi.org/10.4088/jcp.23m15132

Citations

1

Primary Topic

Schizophrenia research and treatment

Type

article

Field-Weighted Citation Impact

0.39

Funders

• Bristol-Myers Squibb
• Eli Lilly and Company
• Pfizer
• AstraZeneca
• Sanofi
• Texas Health and Human Services Commission
• Teva Pharmaceutical Industries
• University of Missouri
• University of Missouri-Kansas City
• Sunovion
• Stony Brook University
• National Institute of Mental Health